Rhythm Pharmaceuticals Inc (RYTM)

07:38 AM

Primecap Management Co. CA Has $378.09 Million Stock Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat

07:38 AM

Nov 18, 2024

Rhythm Pharmaceuticals Announces Five Presentations at ESPE - GlobeNewswire

Nov 18, 2024

Nov 18, 2024

Rhythm Pharma: New Drug Shows 9.6% Weight Loss in Pediatric Obesity Treatment Study | RYTM Stock News - StockTitan

Nov 18, 2024

Nov 15, 2024

Perceptive Advisors LLC's Strategic Acquisition in Rhythm Pharma - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

(RYTM) Proactive Strategies - Stock Traders Daily

Nov 14, 2024

Nov 14, 2024

Rhythm pharmaceuticals CTO Joseph Shulman sells $882,340 in stock By Investing.com - Investing.com Nigeria

Nov 14, 2024

Nov 13, 2024

Rhythm pharmaceuticals CTO Joseph Shulman sells $882,340 in stock - Investing.com

Nov 13, 2024

Nov 13, 2024

Rhythm Pharmaceuticals EVP sells $4.43m in stock By Investing.com - Investing.com Australia

Nov 13, 2024

Nov 13, 2024

Rhythm Pharmaceuticals EVP sells $4.43m in stock - Investing.com

Nov 13, 2024

Nov 13, 2024

Rhythm Pharmaceuticals Announces Publication of Results - GlobeNewswire

Nov 13, 2024

Nov 13, 2024

Rhythm Pharma's Obesity Drug Shows 83% Success in Phase 3 Trial, FDA Priority Review Set | RYTM Stock News - StockTitan

Nov 13, 2024

Nov 13, 2024

Rhythm Pharmaceuticals Announces New Employment Inducement Grants - GlobeNewswire

Nov 13, 2024

Nov 13, 2024

Rhythm Pharmaceuticals Awards 15,750 RSUs to New Employees in Talent Acquisition Push | RYTM Stock News - StockTitan

Nov 13, 2024

Nov 13, 2024

PRIMECAP Management Adjusts Stake in Rhythm Pharmaceuticals - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

Goldman Sachs Group Inc Reduces Stake in Rhythm Pharmaceuticals Inc - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

High Growth Tech Stocks Featuring Three Prominent US Companies - Simply Wall St

Nov 12, 2024

Nov 11, 2024

Rhythm Pharmaceuticals (NASDAQ:RYTM) Reaches New 52-Week HighWhat's Next? - MarketBeat

Nov 11, 2024

Nov 11, 2024

HC Wainwright Issues Pessimistic Outlook for RYTM Earnings - MarketBeat

Nov 11, 2024

Nov 09, 2024

Rhythm Pharmaceuticals' HR chief Pamela Cramer sells $585,940 in stock By Investing.com - Investing.com Australia

Nov 09, 2024

Nov 09, 2024

Insider Selling: Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Insider Sells 4,688 Shares of Stock - MarketBeat

Nov 09, 2024

Nov 08, 2024

Rhythm Pharmaceuticals' HR chief Pamela Cramer sells $585,940 in stock - Investing.com

Nov 08, 2024

Nov 07, 2024

Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $69.00 - MarketBeat

Nov 07, 2024

Nov 07, 2024

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 07, 2024

Nov 07, 2024

Rhythm Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Nov 07, 2024

Nov 07, 2024

Rhythm Pharmaceuticals Inc (RYTM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance UK

Nov 07, 2024

Nov 07, 2024

8,594 Shares in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Acquired by Creative Planning - MarketBeat

Nov 07, 2024

Nov 07, 2024

Rhythm Pharmaceuticals Inc (RYTM) Q3 2024 Earnings Call Highligh - GuruFocus.com

Nov 07, 2024

Nov 06, 2024

Earnings call: Rhythm Pharmaceuticals has reported a successful third quarter in 2024 - Investing.com India

Nov 06, 2024

Nov 06, 2024

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences - GlobeNewswire

Nov 06, 2024

Nov 06, 2024

Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $64.00 at Needham & Company LLC - MarketBeat

Nov 06, 2024

Nov 06, 2024

Rhythm Pharmaceuticals CEO to Present at Major Healthcare Investor Conferences | RYTM Stock News - StockTitan

Nov 06, 2024

Nov 06, 2024

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 06, 2024

Nov 06, 2024

Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Update - GlobeNewswire

Nov 06, 2024

Nov 05, 2024

Rhythm Pharmaceuticals (NASDAQ:RYTM) Reaches New 1-Year HighTime to Buy? - MarketBeat

Nov 05, 2024

Nov 05, 2024

Rhythm Pharma stock soars to all-time high of $55.65 By Investing.com - Investing.com Canada

Nov 05, 2024

Nov 05, 2024

Rhythm Pharma stock soars to all-time high of $55.65 - Investing.com

Nov 05, 2024

Nov 05, 2024

Gastroparesis Drugs Market to Grow by USD 1.42 Billion from 2024-2028, Driven by Rising Diabetes Rates and AI-Driven Market Trend InsightsTechnavio - The Malaysian Reserve

Nov 05, 2024

Nov 04, 2024

Rhythm Pharmaceuticals (NASDAQ:RYTM) Trading 7.4% HigherTime to Buy? - MarketBeat

Nov 04, 2024

Nov 04, 2024

Rhythm Pharmaceuticals Announces Five New Data Presentations at ObesityWeek® 2024 - The Manila Times

Nov 04, 2024

Nov 04, 2024

What's Next: Rhythm Pharmaceuticals's Earnings Preview - Benzinga

Nov 04, 2024

Nov 04, 2024

(RYTM) Investment Analysis - Stock Traders Daily

Nov 04, 2024

Nov 03, 2024

Assenagon Asset Management S.A. Decreases Stock Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat

Nov 03, 2024

Nov 02, 2024

Nisa Investment Advisors LLC Has $3.47 Million Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat

Nov 02, 2024

Oct 30, 2024

Needham & Company LLC Reaffirms Buy Rating for Rhythm Pharmaceuticals (NASDAQ:RYTM) - MarketBeat

Oct 30, 2024

Oct 30, 2024

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Oct 30, 2024